Skip to main content

Table 6 Precision medicine in AIT using innovative tools (biomarkers and e-health)

From: Allergen Immunotherapy (AIT): a prototype of Precision Medicine

• Assessment of prevalence and severity of allergic diseases.

 

• Phenotypic characterisation of allergic patients, stratification of patients, characterisation of severe chronic upper airway disease (SCUAD) patients and characterisation of patients to be treated by AIT.

 

• Randomised controlled trials (placebo-controlled or real life cluster randomised trials): assessment of efficacy (during the allergen exposure) and safety (during AIT administration).

 

• Follow up of patients in clinical settings during AIT.

 

• Follow up of patients in clinical settings after AIT has been stopped.

Â